This slide presentation summarizes Egypt's exports of pharmaceuticals. It shows that Egypt's pharmaceutical exports have been increasing in recent years and make up a growing percentage of Egypt's total exports. The main markets for Egypt's pharmaceutical exports are other countries in the Arab region, which make up 67% of pharmaceutical exports. The presentation also provides data on global pharmaceutical market trends and tariffs applied to Egyptian pharmaceutical products in various importing countries.

1. Egypt’s Exports of Pharmaceuticals
Presented
by
Mahmoud Fath-Allah
Customs and Trade Policy Advisor
April 2, 2012
This slide presentation is made possible by the support of the American people through the U.S.
Agency for international Development (USAID). The contents of this presentation are the sole
responsibility of The Trade Facilitation Project (TFP) under the management of Nathan Associates
Inc. and do not necessarily reflect the views of USAID or the United States Government.

2. Global Pharmaceutical Market, 2005-210
Source: IMS, Health Market Prognosis, March 2011

3. Regional Distribution of Global Pharmaceutical Market
Source: IMS, Health Market Prognosis, March 2011

6. 2.5%
2.0%
1.5%
1.0%
0.5%
0.0%
2,500
2,000
1,500
1,000
500
0
Exports of Medical Industries and Percentage to the Total Exports of All Egypt
Export Councils
2005 2006 2007 2008 2009 2010 2011
Value in Millions LE % to Total Exports Councils
Source: Computed from Data in Egyptian non-oil Foreign Trade – Monthly Digest, Feb. 2012, General Organization for Exports &
Imports Control (GOEIC), http://www.goeic.gov.eg/en/statisticsindex.asp

7. Egypt Exports of Medical Industry Products by share of Main Trade
EU
10%
Arab
67%
USA
0.1%
RoW
22.9%
Partners (2011)
Source: Computed from Data in Egyptian non-oil Foreign Trade – Monthly Digest, Feb. 2012, General Organization for Exports &
Imports Control (GOEIC), http://www.goeic.gov.eg/en/statisticsindex.asp

8. Tariffs applied to "(30) Pharmaceutical products" originating from Egypt.
Selected
importers
Year Harmonised System
Nomenclature Revision
Number of
lines
Total ad valorem
equivalent tariff
(estimated)
India 2009 Rev. 07 214 9.93%
Kazakhstan 2010 Rev. 07 79 0.11%
Libyan Arab
Jamahiriya
2006 Rev. 02 31 0.00%
Pakistan 2008 Rev. 07 54 12.17%
Romania 2010 Rev. 07 46 0.00%
Saudi Arabia 2009 Rev. 07 40 0.00%
Sudan 2011 Rev. 07 32 0.00%
Turkey 2010 Rev. 07 71 0.00%
Yemen 2009 Rev. 07 36 0.65%
USA 2010 Rev. 07 43 0.0%
Source: ITC, Market Access Map, http://www.macmap.org/trademap/Applied.Tariffs.Results.Importers.aspx

9. US Pharmaceutical Imports from Middle East (2001-2011) and it’s Share in 2011
Others
91%
Middle East
9%

11. Thank you